Maintenance fees coming due
13 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Dec 11, 2026. Unpaid by Jun 11, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,314,845 | Benzimidazole Derivatives as PI3 Kinase Inhibitors In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | GlaxoSmithKline LLC | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 9,062,003 | Benzimidazole Derivatives as PI3 Kinase Inhibitors In force Fee due Dec 23, 2026 Lapses if unpaid Jun 23, 2027 · High confidence | GlaxoSmithKline LLC | In force | Dec 23, 2026 | Jun 23, 2027 | High confidence | |
| US 10,357,798 | Vapor Sheath for Liquid Dispensing Nozzle In force Fee due Jan 23, 2027 Lapses if unpaid Jul 23, 2027 · Medium confidence | GlaxoSmithKline LLC | In force | Jan 23, 2027 | Jul 23, 2027 | Medium confidence | |
| US 9,102,677 | Benzodiazepine Bromodomain Inhibitor In force Fee due Feb 11, 2027 Lapses if unpaid Aug 11, 2027 · High confidence | GlaxoSmithKline LLC | In force | Feb 11, 2027 | Aug 11, 2027 | High confidence | |
| US 9,102,685 | Derivatives of Betulin In force Fee due Feb 11, 2027 Lapses if unpaid Aug 11, 2027 · High confidence | GlaxoSmithKline LLC | In force | Feb 11, 2027 | Aug 11, 2027 | High confidence | |
| US 9,156,797 | Benzimidazole Derivatives As PI3 Kinase Inhibitors In force Fee due Apr 13, 2027 Lapses if unpaid Oct 13, 2027 · High confidence | GlaxoSmithKline LLC | In force | Apr 13, 2027 | Oct 13, 2027 | High confidence | |
| US 9,173,872 | Pyrazolopyrimidine Compounds In force Fee due May 3, 2027 Lapses if unpaid Nov 3, 2027 · High confidence | GlaxoSmithKline LLC | In force | May 3, 2027 | Nov 3, 2027 | High confidence | |
| US 10,478,426 | Enhancer of Zeste Homolog 2 Inhibitors In force Fee due May 19, 2027 Lapses if unpaid Nov 19, 2027 · High confidence | GlaxoSmithKline LLC | In force | May 19, 2027 | Nov 19, 2027 | High confidence | |
| US 9,233,934 | Phenyl Amino Pyrimidine Compounds and Uses Thereof In force Fee due Jul 12, 2027 Lapses if unpaid Jan 12, 2028 · High confidence | GlaxoSmithKline LLC | In force | Jul 12, 2027 | Jan 12, 2028 | High confidence | |
| US 9,238,628 | Phenyl Amino Pyrimidine Compounds and Uses Thereof In force Fee due Jul 19, 2027 Lapses if unpaid Jan 19, 2028 · High confidence | GlaxoSmithKline LLC | In force | Jul 19, 2027 | Jan 19, 2028 | High confidence | |
| 3 more maintenance fees coming due in the 12 months from Nov 15, 2026 · Pro | |||||||
10 of 13 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.